HLA‐B gene somatic insertion/deletion mutations in patients with acute myelogenous leukaemia
- 27 July 2018
- journal article
- research article
- Published by Wiley in International Journal of Immunogenetics
- Vol. 45 (6) , 323-328
Abstract
Loss of heterozygosity is considered to be the most common type of tumour‐specific somatic mutation of the human leucocyte antigens (HLA) genes in patients with haematological malignancies. Nevertheless, subtle DNA sequence changes, namely short insertions/deletions, may also abolish the expression of HLA molecules and interfere with routine HLA typing. Two male patients with acute myelogenous leukaemia (AML) were indicated for the search of a suitable donor for allogeneic haematopoietic stem cell transplantation (aHSCT). The patients and their relatives were initially HLA typed by serological and DNA techniques at a low‐resolution level. The HLA high‐resolution (HR) type was obtained by means of sequencing‐based typing (SBT). In both cases, anomalous frameshifts in the sequence were observed in the HLA‐B gene, namely in exon 3 (Case 1, heterozygous deletion of two bases) and exon 4 (Case 2, heterozygous insertion of two bases). In the second case, the insertion variant was associated with a loss of HLA‐B8 expression. To reveal whether these sequence patterns may be caused by somatic mutations in the malignant cells, blood sample in remission (Case 1) and buccal swab sample (Case 2) were collected from the patients. In an important manner, the SBT in these germline samples revealed common HLA‐B*07:02,*15:01 (Case 1) and HLA‐B*08:01,*35:02 (Case 2) types with no evidence for the sequence alteration observed in the initial samples. In conclusion, the insertion/deletion sequence variants of the HLA‐B gene in two patients were limited to the initial blood samples with a substantial proportion of AML cells and thus may be attributed to the somatic mutation in the malignant cells. HLA somatic mutations should be taken into account in patients with haematological malignancies to prevent HLA mistyping and inappropriate selection of an aHSCT donor.Keywords
Funding Information
- Ministerstvo Zdravotnictví Ceské Republiky (MHCZ-DRO(FNOl,00098892))
- Univerzita Palackého v Olomouci (IGA_LF_2018_016)
This publication has 19 references indexed in Scilit:
- Somatic mutation in acute myelogenous leukemia cells imitate novel germline HLA‐A allele: a case reportTissue Antigens, 2014
- Genetic profiling in acute myeloid leukaemia ─ where are we and what is its role in patient managementBritish Journal of Haematology, 2012
- Haploidentical hematopoietic stem cell transplantation for lymphoma with monosomy of chromosome 6 (loss of heterozygosity in the HLA region) — Who should be a donor?Transplant Immunology, 2012
- Chromosomal aberrations and fusion genes in myeloid malignanciesExpert Review of Hematology, 2012
- Somatic mutations in the HLA genes of patients with hematological malignancyTissue Antigens, 2012
- Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomyLeukemia, 2012
- Detection of A B acute lymphoblastic leukaemia blast-specific mutation in HLA-B*39:01International Journal of Immunogenetics, 2011
- Loss of Mismatched HLA in Leukemia after Stem-Cell TransplantationNew England Journal of Medicine, 2009
- DNA sequencing-based HLA typing detects a B-cell ALL blast-specific mutation in HLA-A*2402 resulting in loss of HLA allele expressionLeukemia, 2003
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988